S9 VPAP Adapt (With ASV) Support

  • With ResMed, you won’t need to walk the therapy journey alone. We’re here to offer help and support along the way, so you can get the most out of your ResMed product.

Reference

ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnea.